4.3100
+0.0300
+(0.70%)
At close: January 31 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-2,936.5130
-4,114.2190
-4,646.7650
-4,738.0670
-4,267.1930
Investing Cash Flow
--
--
-500.0000
--
--
Financing Cash Flow
--
--
--
11,454.5450
5,426.8250
End Cash Position
6,839.5600
8,983.0460
13,097.2650
18,244.0300
11,527.5520
Capital Expenditure
--
--
-500.0000
--
--
Issuance of Capital Stock
--
--
--
11,450.8660
5,426.8250
Free Cash Flow
-2,936.5130
-4,114.2190
-5,146.7650
-4,738.0670
-4,267.1930
12/31/2020 - 6/30/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VTVT vTv Therapeutics Inc.
16.19
+10.21%
ICCC ImmuCell Corporation
5.40
-1.91%
IMMP Immutep Limited
2.0900
+0.97%
FLUI.ST Fluicell AB (publ)
0.0576
+3.60%
PSTV Plus Therapeutics, Inc.
1.2400
0.00%
GLSI Greenwich LifeSciences, Inc.
12.94
-1.90%
BDRX Biodexa Pharmaceuticals Plc
4.4061
+3.19%
INAB IN8bio, Inc.
0.2558
+3.19%
IMRN Immuron Limited
2.0420
-4.58%
IMM.AX Immutep Limited
0.3450
-1.43%